BioSpace News Archive

Business

Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced financial results for the first quarter ended March 31, 2024, and provided a business update.

May 9, 2024
·
18 min read
Pharm Country

Trevi Therapeutics to Participate in Upcoming Conferences

Trevi Therapeutics, Inc. today announced that senior management will be attending investor, business development and medical conferences in May and June.

May 9, 2024
·
3 min read
Business

Palatin to Report Third Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on May 15, 2024

Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter fiscal year 2024 operating results on Wednesday, May 15, 2024, before the open of the U.S. financial markets.

May 9, 2024
·
1 min read
Business

Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune diseases, today reported financial results and business highlights for the first quarter ended March 31, 2024.

May 9, 2024
·
13 min read
Drug Development

Apnimed Announces Completion of Enrollment in Phase 3 LunAIRo Study of AD109, the Potential First Nighttime Oral Treatment for Obstructive Sleep Apnea

Apnimed announced the early completion of enrollment in its LunAIRo Phase 3 study designed to examine the efficacy and safety of its lead candidate AD109 compared to placebo at six months and one year.

May 9, 2024
·
7 min read
Pharm Country

Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference 2024

Aquestive Therapeutics, Inc., a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, announced that the management team will participate in The Citizens JMP Life Sciences Conference on May 13, 2024.

May 9, 2024
·
3 min read
Pharm Country

PDS Biotech to Participate in Upcoming May 2024 Investor Conferences

PDS Biotechnology Corporation, a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, announced that the Company will participate in two upcoming investor conferences taking place in May 2024.

May 9, 2024
·
6 min read
Genetown

ORYZON to Provide Corporate Progress Updates at Several Events in May 2024

Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced that its management will give an update on corporate progress at several international events in May.

May 9, 2024
·
8 min read
Biotech Bay

Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting

Reviva Pharmaceuticals Holdings, Inc. announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present new pharmacology data on brilaroxazine as part of two poster presentations at the ASPET 2024 Annual Meeting, to be held in Arlington, VA May 16-19, 2024.

May 9, 2024
·
5 min read
Business

Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, reported financial results for the first quarter of 2024, and provided recent business highlights.

May 9, 2024
·
13 min read